Gland Pharma Limited
GLAND
Kedudukan dalam Saham
#3362
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Harga Saham
$32.02
Modal Pasaran
$5.28B
Perubahan (1 hari)
-3.92%
Perubahan (1 tahun)
46.60%
Negara
IN
Perdagangan Gland Pharma Limited (GLAND)
Kategori
Healthcare
Nisbah P/S bagi Gland Pharma Limited (GLAND)
Nisbah P/S pada October 2026 TTM: 7.47
Menurut laporan kewangan dan harga saham terkini Gland Pharma Limited, nisbah P/S semasa (TTM) ialah 7.47. Pada akhir 2024, nisbah P/S syarikat ialah 5.27.
Sejarah nisbah P/S untuk Gland Pharma Limited dari 2017 hingga 2026
Nisbah P/S pada akhir setiap tahun
| Tahun | Nisbah P/S | Ubah |
|---|---|---|
| 2026 (TTM) | 7.47 | 63.72% |
| 2025 | 4.56 | -13.61% |
| 2024 | 5.27 | -9.26% |
| 2023 | 5.81 | -52.56% |
| 2022 | 12.25 | 7.08% |
| 2021 | 11.44 | 4.38% |
| 2020 | 10.96 | -26.45% |
| 2019 | 14.91 | -20.73% |
| 2018 | 18.80 | -1.35% |
| 2017 | 19.06 | 0.00% |
Nisbah P/S untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/S | Perbezaan Nisbah P/S | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -5.46% |
IN
|
